The Drug-Induced Respiratory Disease Website
V. Myocarditis
V.b Eosinophilic myocarditis
XVI. Hemorrhage - Bleeding - Hematoma(s)
XVI.e Alveolar hemorrhage (AH), diffuse AH (DAH)
XXII. Acute respiratory/cardiorespiratory failure
XXII.b Acute lung injury - ARDS
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.a Pneumonitis (ILD)
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.b Pneumonitis (ILD), acute and/or severe (may cause ARDS)
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.c Eosinophilic pneumonia (pulmonary infiltrates and eosinophilia)
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.f Diffuse alveolar damage (DAD) imaging pattern
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.h Pulmonary fibrosis (may improve but partly following drug discontinuation)
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.j Organizing pneumonia (OP/BOOP) pattern (an area or areas of consolidation on imaging)
XXVIII. Large airway involvement
XXVIII.a Angioedema (may cause UAO, asphyxia and death)
XXXVIII. Miscellaneous - Varia
XXXVIII.k Hypersensitivity reaction (may manifest with fever and/or skin, throat or airway involvement)
XVI. Hemorrhage - Bleeding - Hematoma(s)
XVI.e Alveolar hemorrhage (AH), diffuse AH (DAH)
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.c Eosinophilic pneumonia (pulmonary infiltrates and eosinophilia)
XXXVI. Autoimmune syndromes - Systemic reactions or conditions
XXXVI.j Eosinophilic granulomatosis with polyangiitis (Churg-Strauss)
XIV. Pleural involvement
XIV.a Pleural effusion (uni or bilateral) (can accompany ILD induced by the drug)
XX. Vasculitis
XX.c Vascultis (pulmonary, extrathoracic or systemic) - ANCA status unknown or negative
XXI. Mediastinal involvement/injury
XXI.a Lymphadenopathy (intrathoracic)
XXII. Acute respiratory/cardiorespiratory failure
XXII.b Acute lung injury - ARDS
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.a Pneumonitis (ILD)
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.b Pneumonitis (ILD), acute and/or severe (may cause ARDS)
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.c Eosinophilic pneumonia (pulmonary infiltrates and eosinophilia)
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.f Diffuse alveolar damage (DAD) imaging pattern
XXIX. Small airway involvement
XXIX.d Cough (lone)
XXX. Imaging features
XXX.b Imaging: A miliary pattern (diffuse random micronodules)
XXX. Imaging features
XXX.n Imaging: A 'tree-in-bud' pattern
XXXVI. Autoimmune syndromes - Systemic reactions or conditions
XXXVI.h Myasthenia gravis - Myasthenic-like syndrome
XXXVI. Autoimmune syndromes - Systemic reactions or conditions
XXXVI.i Guillain-Barré (or GB-like) syndrome (w/wo ARF)
XXXVI. Autoimmune syndromes - Systemic reactions or conditions
XXXVI.k Multiple organ dysfunction/failure (MODS/MOF)
XXXVIII. Miscellaneous - Varia
XXXVIII.a Upper airway obstruction other than angioedema or hematoma
XXXVIII. Miscellaneous - Varia
XXXVIII.k Hypersensitivity reaction (may manifest with fever and/or skin, throat or airway involvement)
XII. Pericardial involvement
XII.b Pericardial effusion (w/wo tamponade)
XXXIII. Histopathology (for pulmonary pathology see in ‘Pneumotox’ (a free companion App)
XXXIII.x Granulomatous mediastinal lymphadenopathy
XXXVI. Autoimmune syndromes - Systemic reactions or conditions
XXXVI.c Sarcoid-like granulomatosis (endo-/extrathoracic)
I. Cardiac arrhythmia(s)/dysrhythmia(s) (AF, VT, VF, TdP) - QTc prolongation)
I.l Cardiac- cardiorespiratory/pulmonary arrest
II. Myocardial dysfunction - Heart failure
II.e Acute respiratory or cardiopulmonary failure
VI. Cardiomyopathy
VI.a Cardiomyopathy (acute, subacute, chronic)
XXII. Acute respiratory/cardiorespiratory failure
XXII.e Respiratory failure from ventilatory depression (of neuromuscular cause or causes)
XXII. Acute respiratory/cardiorespiratory failure
XXII.f Rigid chest syndrome - Chest wall rigidity - Stiff/wooden chest
XXVIII. Large airway involvement
XXVIII.d Vocal cord dysfunction, adduction, closure
XXVIII. Large airway involvement
XXVIII.f Laryngospasm (a.k.a. laryngismus)
XXXV. Disordered breathing during sleep
XXXV.b Disordered breathing pattern - Cheynes-Stokes respiration
XXXVIII. Miscellaneous - Varia
XXXVIII.n Hiccup
I. Cardiac arrhythmia(s)/dysrhythmia(s) (AF, VT, VF, TdP) - QTc prolongation)
I.l Cardiac- cardiorespiratory/pulmonary arrest
XXII. Acute respiratory/cardiorespiratory failure
XXII.a Respiratory distress or failure, not otherwise specified
XXVIII. Large airway involvement
XXVIII.d Vocal cord dysfunction, adduction, closure
XXVIII. Large airway involvement
XXVIII.f Laryngospasm (a.k.a. laryngismus)
XXXVIII. Miscellaneous - Varia
XXXVIII.a Upper airway obstruction other than angioedema or hematoma
XII. Pericardial involvement
XII.n Pleuropericarditis - Pleuropericardial effusion (ANA unknown or negative)
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.c Eosinophilic pneumonia (pulmonary infiltrates and eosinophilia)
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.j Organizing pneumonia (OP/BOOP) pattern (an area or areas of consolidation on imaging)